Does ROSUVASTATIN Cause Product dose omission? 77 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Product dose omission have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
77
Reports of Product dose omission with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Product dose omission From ROSUVASTATIN?
Of the 77 reports, 19 (24.7%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which ROSUVASTATIN Alternatives Have Lower Product dose omission Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN